Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Favipiravir (Favipira)”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04907682
What this trial is testing

Pharmacokinetics, Tolerability and Safety of Favipiravir Compared to Ribavirin for the Treatment of Lassa Fever

Who this might be right for
Lassa Fever
Bernhard Nocht Institute for Tropical Medicine 40
Large-scale testing (Phase 3)UnknownNCT04336904
What this trial is testing

Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19

Who this might be right for
COVID-19
Giuliano Rizzardini 100
Large-scale testing (Phase 3)Study completedNCT04349241
What this trial is testing

Efficacy and Safety of Favipiravir in Management of COVID-19

Who this might be right for
Coronavirus Disease (COVID-19)
Ain Shams University 100
Large-scale testing (Phase 3)Study completedNCT04373733
What this trial is testing

Early Intervention in COVID-19: Favipiravir Verses Standard Care

Who this might be right for
Coronavirus Infection
Chelsea and Westminster NHS Foundation Trust 502
Testing effectiveness (Phase 2)Looking for participantsNCT06860334
What this trial is testing

UMIT-2 - Adaptive Phase IIb Platform Trial to Determine the Efficacy and Safety of Therapeutics for CCHF

Who this might be right for
Crimean-Congo Hemorrhagic Fever
Liverpool School of Tropical Medicine 378
Testing effectiveness (Phase 2)Ended earlyNCT02739477
What this trial is testing

Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen

Who this might be right for
Ebola Virus Survivor
Institut National de la Santé Et de la Recherche Médicale, France 2
Testing effectiveness (Phase 2)Ended earlyNCT04448119
What this trial is testing

Control of COVID-19 Outbreaks in Long Term Care

Who this might be right for
COVID-19SARS-CoV-2
Appili Therapeutics Inc. 67
Large-scale testing (Phase 3)Study completedNCT04542694
What this trial is testing

Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

Who this might be right for
COVID-19
Promomed, LLC 200
Testing effectiveness (Phase 2)Study completedNCT02329054
What this trial is testing

Efficacy of Favipiravir Against Ebola (JIKI)

Who this might be right for
Ebola Virus Disease
Institut National de la Santé Et de la Recherche Médicale, France 126
Testing effectiveness (Phase 2)Study completedNCT01728753
What this trial is testing

T-705a Multicenter Study in Adults Subjects With Uncomplicated Influenza

Who this might be right for
Influenza
MDVI, LLC 550
Large-scale testing (Phase 3)Study completedNCT04981379
What this trial is testing

Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

Who this might be right for
Covid19
Health Institutes of Turkey 1,120
Not applicableStudy completedNCT04376814
What this trial is testing

Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19

Who this might be right for
COVID-19FavipiravirKaletra+2 more
Baqiyatallah Medical Sciences University 40
Large-scale testing (Phase 3)Ended earlyNCT05279235
What this trial is testing

Efficacy and Safety of JT001 (VV116) Compared With Favipiravir

Who this might be right for
Moderate to Severe COVID-19
Shanghai Vinnerna Biosciences Co., Ltd. 290
Testing effectiveness (Phase 2)Study completedNCT03394209
What this trial is testing

A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza

Who this might be right for
Influenza, HumanCritical IllnessInfluenza
Capital Medical University 34
Large-scale testing (Phase 3)UnknownNCT04402203
What this trial is testing

Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh

Who this might be right for
COVID-19Favipiravir (Favipira)
Bangladesh Medical Research Council (BMRC) 50
Testing effectiveness (Phase 2)Ended earlyNCT04475991
What this trial is testing

Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults

Who this might be right for
COVID-19
Hospital General de México Dr. Eduardo Liceaga 19
Large-scale testing (Phase 3)Study completedNCT05185284
What this trial is testing

Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19

Who this might be right for
COVID-19
Promomed, LLC 217
Not applicableStudy completedNCT05222113
What this trial is testing

OBSERVATIONAL STUDY OF COMPARISON EFFECTIVITY BETWEEN REMDESIVIR AND FAVIPIRAVIR IN SURABAYA, INDONESIA

Who this might be right for
Duration of HospitalizationClinical Manifestation of COVID-19
Bernadette Dian Novita, MD.,PhD 87
Testing effectiveness (Phase 2)UnknownNCT05155527
What this trial is testing

Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients

Who this might be right for
COVID-19
Mahidol University 200
Not applicableStudy completedNCT04645433
What this trial is testing

Effect of Favipiravir on Mortality in Patients With COVID-19 at a Tertiary Center Intensive Care Unit

Who this might be right for
MortalityIntensive Care Unit
Sisli Hamidiye Etfal Training and Research Hospital 100
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation